MedPath

RESCULA

RESCULA

Discontinued
DIN Number

02245525

Drug Class

Human

Market Date

May 27, 2002

Company
HC

novartis ophthalmics novartis pharmaceuticals (canada) inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02245525
AIG Number0146763001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
S01EE02 UNOPROSTONE
Product Specifications
Dosage FormSolution
Route of AdministrationOphthalmic
AHFS Classification52:92.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

UNOPROSTONE ISOPROPYLActive
Strength: 0.15 %
Monograph: UNOPROSTONE ISOPROPYL

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.